Explore All 146 Divestiture Test/Measurement Equipment Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | November 4, 2010 |
| Target | Accriva Diagnostics |
| Sector | Test/Measurement Equipment |
| Buyer(s) | Warburg Pincus |
| Sellers(s) | Thoratec |
| Deal Type | Divestiture |
| Deal Value | 55M USD |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1966 |
| PE ASSETS | 83.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.
| Deal Context for Buyer | # |
|---|---|
| Overall | 177 of 493 |
| Sector: Test/Measurement Equipment | 1 of 1 |
| Type: Divestiture | 7 of 21 |
| State: California | 21 of 44 |
| Country: United States | 99 of 242 |
| Year: 2010 | 26 of 32 |
| Size (of disclosed) | 48 of 50 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-03 |
Gulf Coast Energy Resources
Houston, Texas, United States Gulf Coast Energy Resources, LLC is a private-equity backed exploration and production company that was formed in 2010 and headquartered in Houston, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-10 |
RDA Microelectronics
Shanghai, China RDA Microelectronics, Inc. is a fabless radio frequency (RF) semiconductor design company in China. RDA designs RF semiconductors to address a broad range of applications including 2G cellular, wireless local loop, and 3G cellular. RDA Microelectronics was founded in 2004 and is based in Shanghai, China. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Medical Products |
| Employees | 950 |
| Revenue | 503M USD (2013) |
Thoratec Corporation is a medical device company with a product portfolio for treating advanced heart failure patients. Thoratec develops, manufactures and markets proprietary medical devices used for circulatory support. Thoratec Corporation was established in 1976 and is headquartered in Pleasanton, California.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Test/Measurement Equipment | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2010 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-25 |
Getinge-Heart Pump Technology
Sweden Getinge-Heart Pump Technology, a minimally invasive, acute cardiac axial flow pump. |
Buy | $9M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-08-03 |
Levitronix-Medical Business
United States Levitronix Medical is a provider of magnetically levitated, bearingless mechanical circulatory support products for cardiac and respiratory assist. CentriMag, Levitronix Medical's lead commercial product, is an extracorporeal, centrifugal flow blood pump used for short-term surgical support. Levitronix Medical also manufactures and markets an acute pediatric surgical support system, known as PediMag in the U.S. and PediVAS in international markets. |
Buy | $110M |
